Abstract:OBJECTIVES:To explore the mechanism of Yigutang mediating the P13K/AKT/GSK-3β signaling pathway to regulate the osteogenic differentiation of bone marrow stromal stem cells to treat osteoporosis (OP). METHODS:Sixty 12-week-old female SD rats were randomly divided into the normal group, model group, Yigutang group, and estrogen group, with 15 cases in each group. In the model group, Yigutang group, and estrogen group, the ovaries on both sides were removed to construct the model, and the bone mineral density (BMD) of the upper metaphysis of the right femur of the rats in each group was detected. The left femur of each group of rats was removed, and the load-deformation curve of the left femur of each group of rats was calculated. The number of osteoblasts was observed by H&E staining. After extracting the right femurs of rats in each group, real-time fluorescent quantitative PCR and Western blot were used to detect the expression levels of genes and proteins related to the P13K/AKT/GSK-3β signaling pathway. RESULTS:The BMD of the upper metaphysis of the right femur in the Yigutang group and the estrogen group was significantly higher than that of the model group (P < 0.05), while both Yigutang and estrogen groups had no significant difference compared with the normal group (P > 0.05). In addition, there was no significant difference between the Yigutang group and the estrogen group (P > 0.05). The elastic load and maximum load of the Yigutang group and the estrogen group were significantly higher than the model group (P < 0.05), but both were lower than the normal group (P < 0.05). There was no significant difference between the Yigutang group and the estrogen group (P > 0.05). The number of osteoblasts in the Yigutang group and the estrogen group was significantly higher than the model group (P < 0.05), but both were lower than the normal group (P < 0.05). There was no significant difference between the Yigutang group and the estrogen group (P > 0.05). The P13K gene expression in the right femoral bone tissue of rats in the Yigutang group and the estrogen group was significantly higher than that in the model group (P < 0.05), and the AKT gene expression did not change significantly (P > 0.05). The gene expression of GSK-3β was significantly lower than that of the model group (P < 0.05). Compared with the normal group, the gene expression of P13K, AKT, and GSK-3β in the right femur bone tissue of the Yigutang group and the estrogen group did not change significantly (P > 0.05). The protein expression of P13K and P-AKt in the right femoral bone tissue of rats in the Yigutang group and the estrogen group was significantly higher than that of the model group (P < 0.05), and the protein expression of AKT did not change significantly (P > 0.05). The protein expression of GSK-3β was significantly lower than the model group (P < 0.05). Compared with the normal group, the protein expression of P13K, AKT, P-AKt, and GSK-3β in the right femoral bone tissue of the Yigutang group and the estrogen group did not change significantly (P > 0.05). CONCLUSIONS:Yigutang can regulate the differentiation of bone marrow stromal stem cells into osteoblasts, which may be achieved by regulating the P13K/AKT/GSK-3β signaling pathway.

Tetrahydroxystilbene Glucoside Regulates Proliferation, Differentiation, and OPG/RANKL/M-CSF Expression in MC3T3-E1 Cells via the PI3K/Akt Pathway

Tetrahydroxystilbene glucoside isolated from Polygonum multiflorum Thunb. demonstrates osteoblast differentiation promoting activity

Protective effect of tetrahydroxystilbene glucoside against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells.

Radix Dipsaci Total Saponins Stimulate MC3T3-E1 Cell Differentiation Via the Bone Morphogenetic Protein-2/Mapk/smad-dependent Runx2 Pathway.

Plastrum Testudinis Extracts Promote BMSC Proliferation and Osteogenic Differentiation by Regulating Let-7f-5p and the TNFR2/PI3K/AKT Signaling Pathway

T52 Attenuates Oncogenic STAT3 Signaling and Suppresses Osteosarcoma.

Γ-Tocotrienol Induced the Proliferation and Differentiation of MC3T3-E1 Cells Through the Stimulation of the Wnt/β-catenin Signaling Pathway.

Gamma-Tocotrienol Stimulates the Proliferation, Differentiation, and Mineralization in Osteoblastic MC3T3-E1 Cells

Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activation

Effects of Genistein, Daidzein and Glycitein on the Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells and on the Adipogenic Trans-Differentiation of Osteoblasts

Polydatin improves osteogenic differentiation of human bone mesenchymal stem cells by stimulating TAZ expression via BMP2-Wnt/β-catenin signaling pathway

Jintiange proteins promote osteogenesis and inhibit apoptosis of osteoblasts by enhancing autophagy via PI3K/AKT and ER stress pathways

Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells

Retraction Note: Polydatin Improves Osteogenic Differentiation of Human Bone Mesenchymal Stem Cells by Stimulating TAZ Expression Via BMP2-Wnt/β-catenin Signaling Pathway

Tridax procumbens flavonoids promote osteoblast differentiation and bone formation

The Mechanism of the Yigutang-Mediated P13K/AKT/GSK-3β Signal Pathway to Regulate Osteogenic Differentiation of Bone Marrow Stromal Stem Cells to Treat Osteoporosis.

Synthetic Osteogenic Growth Peptide Promotes Differentiation of Human Bone Marrow Mesenchymal Stem Cells to Osteoblasts Via RhoA/ROCK Pathway.

IGF-IR Promoted Clonal Cell Proliferation in Myelodysplastic Syndromes Through PI3K and MAPK Pathways

Tetrandrine Attenuates Cartilage Degeneration, Osteoclast Proliferation, and Macrophage Transformation through Inhibiting P65 Phosphorylation in Ovariectomy-induced Osteoporosis

Enhancing Activity of Pleurotus sajor-caju (Fr.) Sing β-1,3-Glucanoligosaccharide (Ps-GOS) on Proliferation, Differentiation, and Mineralization of MC3T3-E1 Cells through the Involvement of BMP-2/Runx2/MAPK/Wnt/β-Catenin Signaling Pathway

Triiodothyronine Potentiates BMP9-Induced Osteogenesis in Mesenchymal Stem Cells Through the Activation of AMPK/p38 Signaling.